Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A musculoskeletal system disorder that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the skeletal muscle α-actin gene (ACTA1). These variants lead to a variety of overlapping adult onset and congenital myopathies characterized by muscle weakness, hypotonia, myopathic face, respiratory dysfunction, and rarely cardiac involvement. Specific skeletal muscle structural lesions visible on muscle biopsy include actin accumulations, nemaline and intranuclear bodies, fiber-type disproportion, cores, caps, dystrophic features and zebra bodies. Disorders associated with ACTA1 pathogenic variants can have autosomal dominant (90%) or recessive (10%) inheritance.
No clinical trials have been registered for alpha-actinopathy.
13 publications have been identified in PubMed for alpha-actinopathy. Research spans Basic Science / Preclinical (62%), Review / Meta-Analysis (15%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 8 | 62% |
Data assembled from 2 of 12 sources · Last updated Oct 3, 2026, 8:09 PM UTC
2 |
15% |
Patient case studies | 1 | 8% |
Disease patterns and progression | 1 | 8% |
New treatment approaches | 1 | 8% |
Chin AC (2026). [PMID: 41691613](https://pubmed.ncbi.nlm.nih.gov/41691613/). *The Journal of physiology*. [Review / Meta-Analysis]
Niehaus I (2026). [PMID: 41372632](https://pubmed.ncbi.nlm.nih.gov/41372632/). *EMBO reports*. [Basic Science / Preclinical]
Gráczer É (2026). [PMID: 41489609](https://pubmed.ncbi.nlm.nih.gov/41489609/). *FASEB journal : official publication of the Federation of American Societies for Experimental Biology*. [Gene Therapy / Novel Therapeutics]
Caramizaru A (2026). [PMID: 41826152](https://pubmed.ncbi.nlm.nih.gov/41826152/). *Neuropathology and applied neurobiology*. [Basic Science / Preclinical]
Pertici I (2026). [PMID: 41243338](https://pubmed.ncbi.nlm.nih.gov/41243338/). *The Journal of physiology*. [Basic Science / Preclinical]
Greve JN (2025). [PMID: 39930656](https://pubmed.ncbi.nlm.nih.gov/39930656/). *The FEBS journal*. [Epidemiology / Natural History]
Lehtonen J (2025). [PMID: 40401444](https://pubmed.ncbi.nlm.nih.gov/40401444/). *Human molecular genetics*. [Case Report / Case Series]
Bar-On Z (2025). [PMID: 40748410](https://pubmed.ncbi.nlm.nih.gov/40748410/). *Journal of clinical immunology*. [Basic Science / Preclinical]
Chiappori F (2025). [PMID: 40092659](https://pubmed.ncbi.nlm.nih.gov/40092659/). *Computational and structural biotechnology journal*. [Basic Science / Preclinical]
Marquardt A (2025). [PMID: 40490999](https://pubmed.ncbi.nlm.nih.gov/40490999/). *FEBS letters*. [Basic Science / Preclinical]